Study of MAR002 in Healthy Men
ConditionAcromegaly
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexMale
Age18-40
SponsorMarea Therapeutics
About this trial
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Eligibility criteria
Qualifiers
Willingness to provide written informed consent
Age 18 to 40
Weight 55 to 95 kg
Body mass index (BMI) 18 to 30 kg/m2
Disqualifiers
History of hypersensitivity to monoclonal antibodies or study drug
Participation in any other investigational drug study
History of cancer
Recent acute illness
Trial design
Treatments tested in this trial
- MAR002
- Placebo
Treatment groups
45 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov